The efficacy of implantable defibrillators (ICD) in the prevention of sudden death has been confirmed by multiple studies and countless patients. This efficacy, however, depends on the device programming, which varies considerably among medical centers and, within a single center, among the various caregivers. While the different settings may need to be optimized according to the characteristics of each device recipient, such as age, type of heart disease, or primary versus secondary prevention, some general programming rules apply to a majority
Abbott SecureSense Defibrillators
